GLP-1 receptor agonists reduce dementia and Alzheimer disease risk in diabetic Patients with CKD

GLP-1RAs therapy may reduce the risk of dementia and Alzheimer's disease in patients with CKD stage 3 or later, offering potential neuroprotective benefits beyond glycemic control. Research is needed to confirm these findings and optimize treatment strategies for this vulnerable population.

Authors

Institutions

Publication Details

Journal
Nephrology Dialysis Transplantation
Published
2026-02-14
DOI
https://doi.org/10.1093/ndt/gfag032
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

GLP-1 receptor agonists reduce dementia and Alzheimer disease risk in diabetic Patients with CKD

Wen-Teng Lee, Jing Tong WANG, Yu-Wei Fang, Ming-Hsien Tsai
Nephrology Dialysis Transplantation
Diabetes Treatment and Management
article

GLP-1 receptor agonists reduce dementia and Alzheimer disease risk in diabetic Patients with CKD

Wen-Teng Lee, Jing Tong WANG, Yu-Wei Fang, Ming-Hsien Tsai
article en

Abstract

GLP-1RAs therapy may reduce the risk of dementia and Alzheimer's disease in patients with CKD stage 3 or later, offering potential neuroprotective benefits beyond glycemic control. Research is needed to confirm these findings and optimize treatment strategies for this vulnerable population.

Nephrology Dialysis Transplantation
Fu Jen Catholic University (TW), Memorial Hospital (US)
Openalex Percentile: Top 55%
Diabetes Treatment and Management
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

GLP-1 receptor agonists reduce dementia and Alzheimer disease risk in diabetic Patients with CKD — Wen-Teng Lee, Jing Tong WANG, et al. · Nephrology Dialysis Transplantation (2026) | TGRS Research Map | TGRS